Organigram agrees to acquire Aurora Cannabis
ACB•Organigram agreed to acquire Aurora Cannabis in a deal valuing Aurora’s fully diluted equity at approximately CAD 561 million. Aurora shareholders will receive CAD 7.80 per share in cash, shares or a combination, subject to proration.
1. Deal terms and timing
The deal includes a CAD 187.5 million private placement with BAT and senior secured credit facilities of up to CAD 210 million. The companies expect more than CAD 50 million in synergies across Canadian and international operations. Closing is expected in January 2027, subject to shareholder, court and regulatory approvals, and cannot occur before January 6.
